Catalytic diesel particulate filters reduce the in vitro estrogenic activity of diesel exhaust by Wenger, Daniela et al.
ORIGINAL PAPER
Catalytic diesel particulate filters reduce the in vitro
estrogenic activity of diesel exhaust
Daniela Wenger & Andreas C. Gerecke &
Norbert V. Heeb & Hanspeter Naegeli & Renato Zenobi
Received: 26 September 2007 /Revised: 14 December 2007 /Accepted: 10 January 2008 /Published online: 9 February 2008
# Springer-Verlag 2008
Abstract An in vitro reporter gene assay based on human
breast cancer T47D cells (ER-CALUX®) was applied to
examine the ability of diesel exhaust to induce or inhibit
estrogen receptor (ER)-mediated gene expression. Exhaust
from a heavy-duty diesel engine was either treated by iron-
or copper/iron-catalyzed diesel particulate filters (DPFs) or
studied as unfiltered exhaust. Collected samples included
particle-bound and semivolatile constituents of diesel ex-
haust. Our findings show that all of the samples contained
compounds that were able to induce ER-mediated gene
expression as well as compounds that suppressed the activity
of the endogenous hormone 17β-estradiol (E2). Estrogenic
activity prevailed over antiestrogenic activity. We found an
overall ER-mediated activity of 1.63±0.31 ng E2 CALUX
equivalents (E2-CEQs) per m3 of unfiltered exhaust. In
filtered exhaust, we measured 0.74±0.07 (iron-catalyzed
DPF) and 0.55±0.09 ng E2-CEQ m−3 (copper/iron-catalyzed
DPF), corresponding to reductions in estrogenic activity of
55 and 66%, respectively. Our study demonstrates that both
catalytic DPFs lowered the ER-mediated endocrine-disrupting
potential of diesel exhaust.
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Abbreviations
AhR Aryl hydrocarbon receptor
ANOVA One-way analysis of variance
Cl Chlorine-enriched diesel fuel (14 μg g−1)
Cu Diesel fuel with copper/iron-based fuel
additive (9.0/7.5 μg g−1)
DMSO Dimethylsulfoxide
DPF Diesel particulate filter
E2 17β-Estradiol
EE2 17α-Ethinylestradiol
E2-CEQ 17β-Estradiol CALUX equivalent
ER Estrogen receptor;
ER-
CALUX®
Estrogen Responsive–Chemically Activated
LUciferase eXpression
F Exhaust treatment by diesel particulate filter
FBS Fetal bovine serum
Fe Diesel fuel with iron-based additive
(4.5 μg g−1)
PCDD/Fs Polychlorinated dibenzodioxins/furans
Ref Reference diesel fuel
RSD Relative standard deviation
xCl Chlorine-enriched diesel fuel (110 μg g−1)
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Introduction
Diesel engines emit a complex mixture of carbonaceous
soot particles and hundreds of particle-bound or gaseous
compounds [1]. Diesel combustion contributes appreciable
numbers of fine (<2.5 μm aerodynamic diameter) and ultra-
fine (<0.1 μm) particles to the air in urban and heavy traffic
areas [2] and in work places such as mines and construction
sites [3]. Exposure to diesel exhaust and particularly to
diesel exhaust particles is associated with airway inflamma-
tion, asthma, allergies, cardiovascular diseases [4, 5], and
probably also with lung cancer [6]. Compounds emitted by
diesel engines exhibit various chemical structures, physi-
cochemical properties, toxicities, and physiological effects.
Some of these compounds are potential or known endocrine
disruptors [7, 8, 9]. By mimicking or antagonizing naturally
occurring hormones and/or by modulating hormonal
responses, endocrine disruptors interfere with the normal
functioning of endocrine systems in humans and animals
and thereby lead to adverse health effects (reviewed in
[10, 11]). Chemicals capable of disrupting the action of sex
hormones (e.g., of estrogens) have received most attention.
This is due to their endocrine-disrupting effects, as observed
in laboratory animals; their potential role in wildlife repro-
ductive problems; and their potential association with
reproductive disorders and hormone-sensitive cancers in
humans [10, 11].
In our study, we investigated the estrogenic and anti-
estrogenic activity of diesel exhaust. We used an in vitro
reporter gene assay, the Estrogen Responsive–Chemically
Activated LUciferase gene eXpression (ER-CALUX®) assay
[12], to detect and measure compounds that induce or inhibit
gene expression mediated by the estrogen receptor (ER).
Alterations in gene expression are thought to represent an
early but critical step in the regulation of biological processes
[11]. The ER, of which two subtypes have been found in
humans (i.e., ERα, ERβ), belongs to the nuclear receptor
superfamily (reviewed in [13]). It functions as a ligand-
inducible transcription factor, mediating the effects of natural
estrogens, of which 17β-estradiol (E2) is the major endog-
enous estrogen. Estrogens regulate the growth, differentiation,
and functioning of diverse target tissues. Compounds that
bind competitively to the ER are defined as direct-acting
estrogenic and antiestrogenic compounds [14]. These ER
ligands act either as agonists or antagonists at the receptor.
Upon binding, ER agonists induce conformational changes
in the receptor, which lead via a number of events to
receptor dimerization, receptor–DNA interaction, and finally
to changes in the transcription rate of estrogen-responsive
genes [13]. In the case of CALUX cells, the ER-controlled
reporter gene coding for luciferase is also expressed [12].
In contrast to ER agonists, antagonists block the action of
estrogens. Direct-acting ER antagonists such as ICI 182,780,
a 7α-alkylsulphinyl analog of E2, bind to the ER compet-
itively and inhibit the transcription of ER-regulated genes
[15]. However, certain compounds do not evoke direct
effects on the estrogen system via binding to the ER. Aryl
hydrocarbon receptor (AhR) agonists, such as polychlorinated
dibenzodioxins and furans (PCDD/Fs), induce antagonistic
effects on the ER signal transduction pathway, probably via
several other mechanisms (reviewed in [16]). In summary,
compounds present in diesel exhaust may exhibit complex
interactions with the ER and its signal transduction pathways.
Estrogen-sensitive reporter gene assays, such as the ER-
CALUX® assay, integrate the ER-mediated activity exhibited
by all estrogenic or antiestrogenic compounds, either known
or unidentified, present in a sample [12].
Preceding in vitro studies have shown that diesel
particles, a fraction of the diesel exhaust, contain potential
endocrine disruptors that may modulate the activity of
estrogens in vivo. For example, Meek [17] reported that
compounds present in extracts of diesel particles activated
the ER in MCF-7 human breast cancer cells and the AhR in
Hepa1c1c7 mouse hepatoma cells. Okamura et al. [18]
observed antiestrogenic activity in MCF-7 cells induced by
extracts of diesel particles. No significant estrogenic activity
was found when testing a single concentration of each
extract; however, a study on the dose-dependent response
was not reported. Wang et al. [19] found weak but clear
estrogenic activity in an extract of diesel particles, using a
human ER recombinant yeast assay. Furuta et al. [8] isolated
nitrophenols from diesel particles and showed that 3-
methyl-4-nitrophenol and 4-nitro-3-phenylphenol exhibited
estrogenic activity in a recombinant yeast assay, in a myo-
metrial contractility assay, and in an in vivo uterotrophic
assay. Other in vivo findings have demonstrated that exposure
to diesel exhaust affects both the male and female reproduc-
tive systems of rats [20–22] and mice [22–24]. Epidemiol-
ogic studies have suggested that occupational exposure to
diesel exhaust elevates the risk of ovarian cancer in female
workers from different fields [25] and decreases semen
quality in motorway tollgate workers [26].
In contrast to previous in vitro investigations, the study
presented herein examines the ER-mediated activity of
integral samples, including particle-bound and semivolatile
constituents of diesel exhaust. Exhaust was collected from a
heavy-duty diesel engine operated according to an eight-
stage test cycle (ISO 8178/4 C1), which covers typical field
conditions. The overall ER-mediated activity was quanti-
fied as equivalents of E2. We also investigated the influence
of dose and exposure time on ER-mediated activity of
diesel exhaust. Furthermore, we evaluated effects of catalytic
diesel particulate filters (DPFs) on emissions of estrogenic
and antiestrogenic compounds.
DPFs were developed to counteract adverse health
effects associated with diesel particles. Most current DPF
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technologies lower the number of emitted particles by more
than 95% [3, 27]. Besides this primary effect, secondary
effects also occur, which result from physical filtering of
particle-associated compounds and from chemical transforma-
tion of exhaust constituents (i.e., formation and degradation)
within DPFs. Unwanted side-reactions, such as halogenation
or nitration of primary exhaust constituents, may lead to
increased emissions of toxic compounds. Conditions in the
DPF that promote such unfavorable secondary effects are
described elsewhere [3, 7]. In summary, primary and
secondary effects of DPFs alter the composition of diesel
exhaust. Thus, the application of DPFs may also affect
emissions of estrogenic and antiestrogenic compounds. As
a consequence, ER-mediated activity of the exhaust will
increase or decrease. For example, under the assumption
that the influence of antiestrogenic compounds is negligible,
a decrease in ER-mediated activity is expected if an appre-
ciable amount of ER agonists is sorbed (i.e., adsorbed or
absorbed [28]) to trapped diesel particles and no secondary
formation of ER agonists occurs.
Three major classes of DPFs can be distinguished depend-
ing on the strategy used for the filtering and combustion of
diesel particles: (i) filters built of porous or fibrous substrates
coated with catalysts, typically noble metals, (ii) filters
consisting of uncoated substrates, which accumulate fuel-
borne catalysts, typically transition metal oxides, and (iii)
uncoated filters, which use active regeneration, for example
burners [1]. DPF regeneration demands a minimum temper-
ature of 550 °C and an oxygen content of 5%, which cannot
be attained without catalytic combustion or additional burners/
heaters [1, 29]. In the present study, we evaluated two
commercial, uncoated, cordierite-based, wall-flow DPFs,
for which soot combustion was catalyzed with either an
iron- or a copper/iron-based fuel additive. We investigated
effects of both DPF systems on the ER-mediated activity of
the exhaust, using either chlorine-free or chlorine-enriched
diesel fuels. As discussed elsewhere [3, 7], experimental
conditions with chlorine-enriched fuel represent a worst
case scenario with respect to the secondary formation of
chlorinated AhR agonists, such as PCDD/Fs.
Experimental
Diesel engine operation, sampling devices, and exhaust
sampling
Exhaust was generated using a heavy-duty diesel engine
with direct fuel injection (type D914T, 6.11 L, 4 cylinders,
105 kW, Liebherr, Bulle, Switzerland). The engine was run
with commercial low-sulfur diesel fuel (class D, SN 181190-
1:2000, density: 824.3 kg m−3, cetane number: 56.0, sulfur:
16 mg kg−1), subsequently called reference fuel, and oper-
ated according to the eight-stage ISO 8178/4 C1 test cycle
valid for construction site engines (“Electronic supplemen-
tary material,” Fig. S1). Emission factors for regulated
pollutants and CO2 are discussed elsewhere [3]. Sampling
was performed according to the filter/condenser method
described in European Standard EN-1948-1 [30]. All-glass
sampling devices (“Electronic supplementary material,”
Fig. S2), consisting of a sampling probe, a quartz fiber filter,
a cooler, a condensate separator, and a two-stage adsorber
unit (XAD-2), were used to obtain samples that included
particle-bound and semivolatile compounds. Samples were
collected in individual sampling devices, which had all been
cleaned and heated up to 450 °C to remove any traces of
organic contaminants. Mass flow proportional aliquots of
undiluted exhaust were taken during two consecutive runs
(200 min) of the test cycle, yielding 4–7 m3 of exhaust per
sample. Table 1 describes the collected samples.
Diesel particulate filters and fuel additives
Two new, uncoated, cordierite-based, monolithic, wall-flow
DPFs (100CPSI, 22.8 L, Greentop, Grävenwiesbach, Germany)
were tested in combination with an iron- or a copper/iron-based
fuel additive as catalysts (ITN, Krakow, Poland). Both additives
were mixed with reference fuel to yield two blends with final
iron and copper/iron concentrations of 4.5 and 9.0/7.5 μg g−1,
respectively, as determined by inductively coupled plasma
optical emission spectrometry (ICP–OES, Vista Pro, Varian,
Palo Alto, CA, USA) [3]. The chemical compositions of these
fuel additives have not been released into the public domain.
Chlorine, in the form of 1,6-dichlorohexane (Fluka,
Buchs, Switzerland), was mixed with reference fuel, resulting
in chlorine levels of 14 and 110 μg Cl g−1, as determined by
wavelength dispersed X-ray fluorescence spectrometry
Table 1 Experimental conditions during the generation of diesel
exhaust samples
Sample codea Chlorine [μg g−1] Fuel additive [μg g−1] DPFb
Ref none (<2) none (<0.1/<0.1) none
Fe none (<2) Fe (4.5) none
FeF none (<2) Fe (4.5) F
Cu none (<2) Cu (9)/Fe (7.5) none
CuF none (<2) Cu (9)/Fe (7.5) F
Cl Cl (14) none (<0.1/<0.1) none
ClFe Cl (14) Fe (4.5) none
ClFeF Cl (14) Fe (4.5) F
ClCuF Cl (14) Cu (9)/Fe (7.5) F
xClCuF xCl (110) Cu (9)/Fe (7.5) F
a A low-sulfur diesel fuel was used in all experiments: Ref, reference
fuel; Fe, reference fuel with iron-based additive; Cu, reference fuel
with copper/iron-based additive; Cl, xCl, chlorine-enriched reference
fuel; F, exhaust treatment by diesel particulate filter (DPF). b Two new,
uncoated, cordierite-based, wall-flow DPFs (Greentop) were tested
Anal Bioanal Chem (2008) 390:2021–2029 2023
(WD-XRF, PW 2400, Philips, Eindhoven, the Netherlands)
[3]. This simulated a worst case scenario for the secondary
formation of chlorinated AhR agonists such as PCDD/Fs [3,
7]. Hence, the effects of both DPFs on the ER-mediated
activity of the exhaust were studied using chlorine-free
(<2 μg Cl g−1 [3]) and chlorine-enriched fuels (Table 1).
Sample extraction
Solvents were pro-analysis quality or better, and were pur-
chased from Merck (Darmstadt, Germany) or Biosolve
(Valkenswaard, The Netherlands). The details of the sample
extraction are given elsewhere [7]. Each sampling device
was rinsed with solvents (acetone, toluene, dichloromethane),
which were subsequently pooled with the extracted condensate.
The pooled extract was concentrated, transferred to toluene, and
used to extract adsorbents and filter materials in a Soxhlet
apparatus for 24 h. The Soxhlet extract was concentrated to a
final volume of approximately 1 ml. Five percent (w/w) was
transferred to a volumetric flask and adjusted to 20 ml. From
this, 0.25–0.75 ml were used to prepare samples for ER-
CALUX® analysis. The solvent was evaporated (50 °C, N2)
and, at the point of dryness, 0.01 ml of dimethylsulfoxide
(DMSO, extra pure, Merck, Darmstadt, Germany) was added.
Samples in DMSO were stored in the dark at 4 °C.
Blank control and sampling spike
A sampling device that was not used for sampling was
extracted and prepared for assay analysis as described above.
This yielded a blank control covering sampling, extraction,
and sample preparation for assay analysis. The average
sample volume (5.8 m3) was used to calculate the assay
response of the blank control per m3 of diesel exhaust. We
determined an E2-CEQ concentration of 0.12±0.04 ng E2-
CEQ m−3 in the blank control. This was 5–16 times below
the concentrations detected in the exhaust samples.
As described elsewhere [7], a 13C-labeled mixture of
compounds (naphthalene, phenanthrene, pyrene, and
1,2,3,4,6,7-hexachlorodibenzodioxin) was spiked to the
sampling devices to estimate overall sampling and work-
up recoveries. The final DMSO solution of the sampling
spike did not exhibit any detectable ER-mediated activity.
Reporter gene assay
The ER-CALUX® assay is an in vitro reporter gene assay
used to detect ER-mediated gene expression [12]. The assay is
based on human breast adenocarcinoma T47D cells that are
stably transfected with the ER-controlled luciferase reporter
gene construct pEREtata-Luc (i.e., T47D.Luc cells). ER ago-
nists induce luciferase gene expression in a dose-dependent
manner and are indirectly detected via luciferase activity.
Cell culture and assay analyses were performed as
previously described [31]. All media and supplements used
were from Gibco (Paisley, Scotland). T47D.Luc cells (BDS,
Amsterdam, The Netherlands) were seeded in 96-well
microtiter plates (Nunc, Rochester, NY, USA) at a density
of 10,000 cells per well and were maintained in 0.1 ml
D-MEM/F-12 phenol red free medium, which was supple-
mented with NaHCO3 (1.26 g L
−1), 1% (v/v) nonessential
amino acids, and 5% (v/v) dextran-coated charcoal-stripped
fetal bovine serum (FBS, Australian origin). After 24 h of
incubation (37 °C, 5% CO2, 100% relative humidity), the
medium was renewed and cells were incubated for another
24 h. Sample extracts, solvent controls, a plate internal
reference compound (EE2), and a serial dilution of E2, all in
DMSO, were diluted 1000-fold in D-MEM/F-12 (containing
NaHCO3, amino acids, stripped FBS). This yielded expo-
sure media with a final DMSO concentration of 0.1% (v/v).
After removing the medium from the microtiter plates,
T47D.Luc cells were exposed in triplicate to 0.1 ml of
exposure medium. ER-mediated activity was quantified
after an exposure time of 24 h. Triplicate analysis of each
sample was repeated in a total of 3–4 independent exposure
experiments. To assess the influence of dose and time on
ER-mediated activity, cells were exposed for 12, 24, 48,
and 72 h with a dilution series of samples Ref and xClCuF
(Table 1). After the exposure of cells, the medium was
removed and 0.05 ml lysis reagent (Promega, Madison, WI,
USA) was added. Luciferase activity was measured as
relative light units (RLUs) on a microplate luminometer
(MLX, Dynex, Chantilly, VA, USA) using luciferase assay
reagent [31]. All RLU values were corrected for back-
ground activity detected in the presence of DMSO alone.
Data obtained from the E2 dilution series were fitted to a
sigmoid curve (y=a0/[1+(x/a1)
a2]; y, measured activity in
RLUs; x, E2 concentration in well; a0, maximum activity in
RLUs; a1, EC50; a2, slope parameter; user-defined curve fit
in Microsoft Excel 2003). Luciferase activities induced by
extracts of diesel exhaust were converted to E2-CEQ
concentrations using the inverse function of the fitted E2
curve (x=a1([a0/y−1]1/a2)). Details on the cell culture and
quality assurance/quality control for assay analysis are given
in the “Electronic supplementary material.” An ER antago-
nist, ICI 182,780 (Tocris Bioscience, Avonmouth, UK) [15],
was mixed with E2 (3 pM, 10 pM) and with two samples
(Ref, xClCuF), yielding a final concentration of 10 nM ICI
182,780 [12] and 0.2% DMSO. This was done to test whether
the detected luciferase activity was ER-mediated or not.
Mixture effect of 17β-estradiol (E2) and diesel exhaust
Extracts of diesel exhaust were tested in combination with a
low concentration of E2 (3 pM) [12] to assess whether
luciferase activities induced by E2 and diesel exhaust are
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additive or compounds present in diesel exhaust suppress
the activity of E2. Stably transfected cells (T47D.Luc) were
exposed for 24 h to mixtures of E2 and exhaust samples at
a final DMSO concentration of 0.2%. On the same plate, E2
(3 pM) and samples were analyzed individually (0.2%
DMSO). The same sample dilutions were used to quantify
the overall ER-mediated activity after 24 h of exposure.
Luciferase activities, induced by E2 alone (3 pM) and samples
alone, were converted into pM E2-CEQs using the fitted
dose–response curve of E2. The arithmetic sum of the E2-
CEQ concentration of E2 and of a sample yielded the
expected estrogenic activity of the mixture, assuming that
the activities were additive. The actually measured estrogenic
activity of the mixtures was expressed as a percentage of the
expected E2-CEQ concentration.
Statistics
Single-factor ANOVA with post hoc testing (Tukey) was
performed for multisample comparisons (Systat 10).P-values
are mentioned in the “Results and discussion” section.
Results and discussion
Suitability of the ER-CALUX assay to investigate diesel
exhaust
The ER-CALUX® assay was used to detect and quantify
constituents of diesel exhaust that trigger 17β-estradiol
(E2)-like gene expression. To test whether measured
luciferase activities were estrogen receptor (ER)-mediated
or induced by other pathways, we added an antagonist for
the ER (10 nM ICI 182,780) to two solutions of E2 (3 pM
and 10 pM), to a sample of unfiltered exhaust (Ref,
Table 1), and to a sample of filtered exhaust (xClCuF,
Table 1). As shown in Fig. 1, luciferase was expressed in
the presence of E2 as well as in the presence of the exhaust
samples. After the addition of the antagonist (ICI 182,780),
luciferase induction by E2 and by both samples was
completely inhibited. Cells were examined under the light
microscope at the beginning and at the end of an exposure
experiment. No morphological changes were evident that
pointed to cytotoxic effects induced by the tested mixtures.
Thus, E2 and both diesel exhaust samples exhibited ER-
mediated activity in the ER-CALUX® assay.
Figure 2 shows the dose–response curve of E2, the
reference compound used. Unfiltered (Ref) as well as DPF-
treated exhaust (xClCuF) induced a dose-dependent re-
sponse, which was similar to the lower part of the E2 curve
(Fig. 2). For both exhaust samples, a full dose–response
curve could not be achieved due to the high viscosity and/
or precipitation that occurred in highly undiluted samples.
Nevertheless, quantitative analysis was possible, because
the dose-dependent activity of the exhaust samples was
found to lie between the limit of quantification (LOQ) and
the 25% effect concentration (EC25) of E2. For the defini-
tion of the LOQ, please see the “Electronic supplementary
material.” To calculate E2 CALUX equivalent (E2-CEQ)
concentrations, we selected sample dilutions that induced
luciferase activity near to the LOQ, but not above 20% of
the maximal induction level of E2 (i.e., activity at EC20). It
has been found that CALUX analyses performed on the
lower part of the curve of the reference compound result in
more precise and less variable data, and thus give more
reliable results [32].
The ER-CALUX® assay is based on living cells that may
be affected by numerous factors which may vary over time;
for example, variations in cultivation conditions or varia-
tions in cell numbers per well of a plate. For each sample,
determination of the E2-CEQ concentration was repeated
by the same operator on 3–4 different days. The relative
standard deviation (RSD) of these interplate determinations
was 3–19%. This is well below 30% RSD, a quality
criterion commonly accepted for bioassay analyses of food
and feedstuffs [32].
Estrogen receptor (ER)-mediated activity of unfiltered
diesel exhaust
After an exposure time of 24 h, all tested extracts exhibited
ER-mediated activity, which was expressed as E2-CEQ
concentrations (Fig. 3). For diesel exhaust generated with
Fig. 1 Estrogen receptor (ER)-mediated luciferase induction (ER-
CALUX®, 24 h of exposure) of 17β-estradiol (E2; 3 pM, 10 pM; gray
columns) and samples of unfiltered and filtered diesel exhaust (Ref,
xClCuF; black columns). The diesel exhaust samples represent
different sample volumes. No induction was detected (i.e., <LOD)
after the addition of an antagonist for the ER (10 nM ICI 182,780;
with antagonist). Data are expressed as luciferase induction in percent
of the highest calibration point used (60 pM E2). Columns show the
means of triplicate determinations in one exposure experiment
(relative standard deviation <10%)
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reference fuel (sample Ref), we determined a concentration
of 1.63±0.31 ng E2-CEQ m−3 of exhaust. ER-mediated
activities per kWh and per L of consumed diesel fuel are
mentioned in the “Electronic supplementary material”
(Table S1). So far, substituted phenols and their derivatives
as well as PAHs and their derivatives have been identified
as compounds with known or suspected ER-mediated
activities present in diesel exhaust [8, 9, 19]. In comparison
to the reference point (Ref), the E2-CEQ concentrations
were lowered when the reference fuel was blended with the
iron- or copper/iron-based catalyst (Fig. 3). We measured
1.31±0.13 ng E2-CEQ m−3 in sample Fe and 1.05±0.07 ng
E2-CEQ m−3 in sample Cu. The observed decrease was
significant for the copper/iron-based sample (p=0.001), but
not for the iron-based sample (p=0.146). We conclude that,
even in the absence of a DPF, the copper/iron-based
catalyst reduced the estrogenic activity of the exhaust by
36%. As shown in Fig. 3, the presence of some chlorine
(14 μg Cl g−1) did not affect the ER-mediated activity of
the emitted exhaust. We found 1.62±0.24 ng E2-CEQ m−3
in the chlorine-based sample (Cl). Likewise, the combined
use of chlorine (14 μg Cl g−1) and the iron-based catalyst
did not exhibit a significant effect on ER-mediated activity
(p=0.720). We measured 1.83±0.17 ng E2-CEQ m−3 (ClFe).
The effect of chlorine in combination with the copper/iron-
based catalyst was not evaluated.
As mentioned, blending of reference diesel fuel with the
copper/iron-based catalyst resulted in a decrease of the E2-
CEQ concentration by 36%. We suppose that the copper/
iron-based catalyst converted some of the ER agonists to
nonactivating compounds, for example by oxidation of
functional groups crucial for receptor binding. However, the
use of metal-based fuel additives, which unavoidably leads to
the formation of secondary nanoparticles [29], is allowed
only in combination with efficient filter technology. For the
DPFs tested in this study, the blending of fuel with catalysts
is necessary to properly combust soot trapped in DPFs.
Besides the use of catalytic fuel additives, catalyst-coated
DPFs have also been successfully introduced [27].
Effects of diesel particulate filters on ER-mediated activity
DPFs are increasingly used for on- and off-road applica-
tions due to more stringent regulations for particulate matter
emissions; for example, in several European countries, in
Japan, and in the United States [1, 3]. Therefore, we were
interested in the effects of DPFs on the ER-mediated
activity of the exhaust. In addition to samples of unfiltered
exhaust, samples of filtered exhaust were analyzed using
the ER-CALUX® assay. Effects of the two additive-catalyzed
DPF systems on the emissions of estrogenic and antiestro-
genic compounds were studied using chlorine-free and
chlorine-enriched diesel fuels (Table 1).
Figure 3 illustrates that both DPFs clearly lowered E2-
CEQ concentrations. Compared to the reference point (Ref),
the emitted E2-CEQ concentration was reduced by 55% in
case of the iron-catalyzed DPF (p<0.001) and by 66% in
case of the copper/iron-catalyzed DPF (p<0.001). Mean
E2-CEQ concentrations of 0.74±0.07 (FeF) and 0.55±0.09
(CuF) ng E2-CEQ m−3 were found. These findings dem-
onstrate a beneficial secondary effect of the two tested
DPFs in respect to emissions of ER ligands. The observed
decrease reflects effects of physical filtration and effects of
the catalysts on compounds showing ER-mediated activity.
Consequently, the application of catalytic DPFs is expected
to reduce the ER-mediated endocrine-disrupting potential
of the exhaust. Furthermore, our results indicate that particles
trapped in DPFs must act as carriers for a substantial fraction
of the ER ligands present in diesel exhaust. The approach
used does not provide information on individual estrogenic
and antiestrogenic compounds. However, further efforts
are needed to investigate differences in the compositions
of the active fractions of filtered and unfiltered exhaust;
for example, through the combined use of the ER-CALUX®
assay and chemical analysis.
According to our considerations in the “Introduction,”
we supposed that a decrease in estrogenic activity would be
observed if an appreciable amount of estrogenic compounds
is sorbed to trapped particles. Consequently, those estrogenic
Fig. 2 Dose–response curves of 17β-estradiol (0.6–60 pM E2;
rhombs), a sample of unfiltered diesel exhaust (Ref; circles), and a
sample of diesel exhaust treated by a diesel particulate filter (xClCuF;
triangles) (ER-CALUX®, 24-h data). Data are expressed as luciferase
induction in percent of the 60 pM E2 calibration point. Each data
point represents the mean ± standard deviation of a triplicate
determination in one exposure experiment
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compounds still released from the DPF would either not be
sorbed to trapped particles or would be emitted at higher
operating temperatures or formed in the DPFs (e.g., by
selective hydroxylation of primary exhaust constituents).
Interestingly, the efficiency of both DPFs at reducing the ER-
mediated activity of the exhaust was lower than their
efficiency at reducing the AhR-mediated activity. Both DPFs
reduced emissions of AhR agonists by almost 90% [7].
The addition of chlorine to the reference fuel (i.e., 14 or
110 μg Cl g−1) did not influence the efficiencies of both
DPFs at lowering the estrogenic activity of the exhaust.
E2-CEQ concentrations in samples FeF and ClFeF and
accordingly in samples CuF, ClCuF, and xClCuF did not
differ from each other (Fig. 3). In a preceding in vitro
study [7], we observed that AhR-mediated activity of the
exhaust was moderately increased compared to all other
DPF-treated samples when the copper/iron-catalyzed DPF
was used in combination with diesel fuel with a high
chlorine content (sample xClCuF, Table 1). This was due to
an intense secondary formation of PCDD/Fs, as previously
detected by chemical analysis [3]. PCDD/Fs activate the
AhR and have been shown to induce antiestrogenic effects
[16]. Although a moderate increase of the overall AhR-
mediated activity was found for sample xClCuF [7], we did
not observe a suppressing effect on the total ER-mediated
activity in comparison to other samples of filtered exhaust
(Fig. 3).
Mixture effect of 17β-estradiol (E2) and diesel exhaust
As discussed, exhaust treatment by DPFs lowered the
estrogenic activity of the exhaust. We hypothesized that this
resulted either from physical filtering of ER ligands com-
bined with effects of the catalysts or from a secondary
formation of compounds that suppress estrogenic activity.
To verify if antiestrogenic compounds are relevant in this
context, exhaust samples were mixed with E2 and the
mixtures were tested using the ER-CALUX® assay.
Figure 4 shows that all mixtures exhibited ER-mediated
activity below the expected additive activity, which was
defined as the sum of the individually tested activities of E2
and of diesel exhaust. ER-mediated activity of the mixtures
was even below the activity of E2 alone for samples ClFe,
Cu, and CuF. Cytotoxic effects exhibited by the mixtures
were not observed. These findings point to the presence of
exhaust constituents that are able to suppress the activity of
E2. Antiestrogenic activity has also been observed in earlier
in vitro studies, for example by Okamura and coworkers.
[18]. Another study showed that monohydroxy derivatives
of PAHs present in diesel exhaust show estrogenic as well
as antiestrogenic activities (reviewed by [22]).
As illustrated by Fig. 4, there was no difference in the
additivity between mixtures containing samples of unfil-
tered exhaust and mixtures containing samples of filtered
exhaust. Thus, we suggest that exhaust treatment by DPF
lowers the estrogenic activity of the exhaust by reducing
emissions of ER ligands, but not via the secondary formation
of antiestrogenic compounds.
ER-mediated activity of diesel exhaust over varying
exposure times
We used an exposure time of 24 h to determine the E2-CEQ
concentrations of the ten samples collected (Table 1). To
test if ER-mediated activity of diesel exhaust changes over
time, we exposed T47D.Luc cells to a sample of unfiltered
exhaust (Ref) and to a sample of DPF-treated exhaust
Fig. 3 Overall estrogenic activity (ER-CALUX®, 24-h data) of
unfiltered (black bars) and filtered (gray bars) exhaust. Activity is
expressed as 17β-estradiol CALUX equivalents per m3 of diesel
exhaust (E2-CEQ m−3). Experimental conditions: Ref, reference fuel;
Fe, fuel with iron-based catalyst (4.5 μg Fe g−1); Cu, fuel with copper/
iron-based catalyst (9.0 μg Cu g−1; 7.5 μg Fe g−1); Cl, chlorine-
enriched fuel (14μg Cl g−1); xCl, chlorine-enriched fuel (110 μg Cl g−1);
F, exhaust treatment by diesel particulate filter. Each bar represents the
mean ± standard deviation of 3–4 independent exposure experiments.
(***, p≤0.001, compared with Ref)
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(xClCuF) at various exposure times of 12, 24, 48, and 72 h.
Longer exposure experiments were not conducted because
ideal conditions for cell culture could not be maintained
(e.g., due to acidification of the medium).
Figure 5 illustrates that ER-mediated activity was nearly
constant from 12 to 72 h of exposure. Exhaust treatment by
DPF did lower the ER ligand level compared to the
reference sample (Ref), but did not affect the ER-mediated
activity during the tested exposure times. Figure 5 indicates
that ER ligands were not biotransformed into nonactivating
compounds by T47D cells within 72 h. This may be
because either the exposed cells do not possess the required
metabolic pathways or because ER ligands in diesel exhaust
are not degradable. So far, the metabolic capacity of in vitro
bioassays for estrogenicity is not well understood [33]. It
has been reported that T47D breast cancer cells express the
cytochrome P450 enzymes [12, 16], which are involved in
the hydroxylation of estrogens and xenobiotics. Thus,
T47D.Luc cells may possess some but probably not much
metabolic capability. In contrast to ER-mediated activity,
AhR-mediated activity of unfiltered as well as filtered
exhaust decreased by more than 90% over a time period of
72 h [7], as previously detected using an in vitro reporter
gene assay based on rat hepatoma cells (DR-CALUX®).
This decrease was expected, because liver cells are char-
acterized by their ability to metabolize exogenous and
endogenous compounds, the AhR is involved in the initial-
ization of biotransformation pathways, and certain AhR
agonists are known to bemetabolized within a short time [34].
Conclusions
Our findings confirm that diesel exhaust contains com-
pounds that are able to induce ER-mediated gene expression,
as well as compounds that are able to suppress E2-induced
activity [8, 17–19]. Estrogenic activity prevailed over anti-
estrogenic activity in the extracts analyzed. In unfiltered
diesel exhaust (Ref), we measured an overall concentration
of ER agonists of 1.6±0.3 ng E2-CEQ m−3. This exceeded
E2-CEQ concentrations found in urban air particulate matter
[35, 36] by a factor of 5–70. Hence, diesel engines operated
without DPFs seem to be an important source of atmospheric
ER ligands. These potential endocrine disruptors may
modulate the activity of endogenous estrogens in humans
and animals and so may lead to adverse health effects [11].
Diesel engine emissions are ubiquitous in the environ-
ment. In addition to the frequent use of diesel-powered
Fig. 5 Overall estrogenic activity of a sample of unfiltered diesel
exhaust (Ref; squares) and a sample of exhaust treated by a diesel
particulate filter (xClCuF; triangles), determined using the ER-
CALUX® assay with varying exposure times (12–72 h). Estrogenic
activities were expressed as E2 CALUX equivalents per m3 of diesel
exhaust (E2-CEQ m−3). Each data point represents the mean of a
triplicate determination in one exposure experiment (relative standard
deviation ≤25%)
Fig. 4 Expected and measured mixture effects of 3 pM 17β-estradiol
and unfiltered or filtered diesel exhaust. Estrogenic activities of 17β-
estradiol (E2 alone; white bars) and of diesel exhaust (sample alone;
gray bars) were measured individually, converted into pM E2
CALUX equivalents (E2-CEQs), and summed, yielding the expected
activities of the mixtures. The actually measured E2-CEQs induced by
the mixtures (black bars) were expressed as percentages of the
expected activity. (Sample Cl was not measured)
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equipment in various workplaces, the use of diesel-fueled
passenger cars is expected to increase. The market share of
diesel cars is approaching 40% of new vehicle registrations
today, and will most likely reach the 50% mark in Europe
in the near future [27]. Our study shows that the DPFs
tested lowered the E2-CEQ concentrations by 55 and 66%,
and thus lowered the emissions of ER ligands with potential
endocrine-disrupting properties. Hence, DPF applications
may be of particular importance for persons that work or
live at places exposed to diesel exhaust [25, 26]. Such places
are, for example, underground workplaces where diesel-
powered equipment is used (e.g., mines, tunnels) and heavy
traffic areas with impaired exchange of air (e.g., urban
canyons, tollgate cabins). We observed a better efficiency of
the copper/iron-catalyzed DPF at reducing the ER-mediated
activity of the exhaust. However, investigation of the PCDD/
F formation potential showed that copper-catalyzed DPFs
should not be recommended for use, because substantial
amounts of PCDD/Fs were formed in this DPF under certain
conditions [3]. Hence, to approve DPF systems for use,
secondary effects of DPFs should not be assessed solely
based on the analysis of a single group of harmful compounds.
The ER-CALUX® assay has proven to be a valuable tool
for studying estrogenic and antiestrogenic constituents of
diesel exhaust and examining secondary effects of DPFs on
emissions of potential endocrine disruptors. In the future,
bioassays may be a useful approach for assessing the
efficiency of DPF systems or testing other exhaust treatment
technologies on a larger scale.
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